We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
PACS Group
PACS
$7.3B
| $17.6M | 0.02% |
457,895
-553,011
| -55% | -$12.1M |
|
652
3M
MMM
$83.4B
| $17.6M | 0.02% |
+109,702
| New | +$17.9M |
|
653
Power Integrations
POWI
$3.93B
| $17.5M | 0.02% |
493,708
+78,968
| +19% | +$2.99M |
|
654
Guardant Health
GH
$20.7B
| $17.5M | 0.02% |
171,206
-70,100
| -29% | -$6.27M |
|
|
GTY
655
Getty Realty Corp
GTY
$2.19B
| $17.5M | 0.02% |
637,865
+396,897
| +165% | +$11M |
|
656
AngloGold Ashanti
AU
$38.8B
| $17.5M | 0.02% |
204,705
+16,403
| +9% | +$1.28M |
|
657
CALL
Walmart Inc
WMT
$909B
| $17.4M | 0.02% |
+156,600
| New | +$16.8M |
|
658
Infosys
INFY
$46.5B
| $17.3M | 0.02% |
972,236
-1,113,725
| -53% | -$19.3M |
|
659
Southern Copper
SCCO
$144B
| $17.2M | 0.02% |
122,469
-354,178
| -74% | -$46.9M |
|
660
Utz Brands
UTZ
$638M
| $17.2M | 0.02% |
1,658,502
+1,184,571
| +250% | +$12.8M |
|
661
United Natural Foods
UNFI
$2.97B
| $17.2M | 0.02% |
510,712
+153,109
| +43% | +$5.69M |
|
|
SEZL
662
Sezzle
SEZL
$5.87B
| $17.2M | 0.02% |
270,881
-213,927
| -44% | -$14.6M |
|
|
LTM
663
LATAM Airlines Group S.A.
LTM
$15.1B
| $17M | 0.02% |
315,586
-277,081
| -47% | -$13.1M |
|
|
KLAR
664
Klarna Group
KLAR
$7.09B
| $17M | 0.02% |
588,351
+11,178
| +2% | +$384K |
|
665
Reliance Steel & Aluminium
RS
$20.2B
| $17M | 0.02% |
+58,680
| New | +$16.5M |
|
666
Edgewise Therapeutics
EWTX
$4.28B
| $16.9M | 0.02% |
+681,921
| New | +$13.7M |
|
|
EVMN
667
Evommune Inc
EVMN
$437M
| $16.9M | 0.02% |
+988,200
| New | +$18.6M |
|
|
HUT
668
Hut 8
HUT
$10.3B
| $16.9M | 0.02% |
+367,063
| New | +$16.2M |
|
669
Universal Display
OLED
$3.75B
| $16.9M | 0.02% |
144,387
+81,522
| +130% | +$10.6M |
|
670
Antero Resources
AR
$10.4B
| $16.8M | 0.02% |
488,409
-1,144,218
| -70% | -$38.7M |
|
|
DQ
671
Daqo New Energy
DQ
$821M
| $16.7M | 0.02% |
+567,509
| New | +$17.3M |
|
672
Cognizant
CTSH
$21.2B
| $16.7M | 0.02% |
201,502
+198,436
| +6,472% | +$14.8M |
|
673
Ocular Therapeutix
OCUL
$1.96B
| $16.7M | 0.02% |
1,377,203
-224,246
| -14% | -$2.72M |
|
|
674
CALL
Eli Lilly
LLY
$1.05T
| $16.7M | 0.02% |
15,500
+3,200
| +26% | +$3.06M |
|
675
Academy Sports + Outdoors
ASO
$3B
| $16.6M | 0.02% |
+331,632
| New | +$16.4M |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.